earnings
confidence high
sentiment positive
materiality 0.75
KORU Medical reports record Q1 revenue of $9.6M, up 18% YoY; raises FY2025 guidance
KORU Medical Systems, Inc.
2025-Q1 EPS reported
$0.03
revenue$9,635,075
- Core revenue (Domestic + International) grew 21% YoY to $9.4M; International up 35.6%.
- Gross margin improved 50 bps to 62.8%; gross profit $6.0M, up 19%.
- Net loss narrowed; adjusted EBITDA improved to ($0.2M) from ($0.9M) prior year.
- FY2025 revenue guidance raised to $38.5-39.5M from $38-39M; gross margin guidance reiterated at 61-63%.
- Plans to submit two drugs for FDA 510(k) clearance with Freedom Infusion System by year-end.